Both Private and Public Sectors along with Academia Come Together at the 2013 BIO International Convention

  Both Private and Public Sectors along with Academia Come Together at the
  2013 BIO International Convention

 The BIO Alliance Zone and Translational Research Forum to be featured at the
                        global event for biotechnology

2013 BIO International Convention

Business Wire

WASHINGTON -- March 14, 2013

Universities have historically been on the front lines of translating
innovative research into novel medicines and technologies useful to patients.
With that in mind, the 2013 BIO International Convention will look to
highlight the role of academia in the advancement of the biotechnology field
through the BIO Alliance Zone and the Translational Research Forum. Hosted by
the Biotechnology Industry Organization (BIO), the Convention, celebrating its
20^th anniversary, will take place April 22-25, 2013 at McCormick Place in
Chicago, Ill.

“With 70% of academic and research institutions at the Convention
participating in partnering, the BIO Alliance Zone, Translational Research
Forum and programs focused on the link between academia, industry
representatives and investors is invaluable,” said BIO President and CEO, Jim

The BIO Alliance Pavilion: Academic Zone is dedicated to academic and research
institutions and serves as a pavilion for academic and industry partnering
meetings as well as provides a venue for highlighting the involvement of
academia in the Convention and the industry as a whole. The Academic Zone will
allow companies to discover new funding mechanisms, energize pipeline and drug
development opportunities, and connect with innovative academic stakeholders.

A special program dedicated to exploring ways that the private sector,
academia and the public sector, in both emerging and developed markets, can
leverage existing mechanisms and pursue partnerships to help make innovative
products available, The Translational Research Forum: Moving from
Translational to Transformational, will survey best practices and outcomes
from partnerships in transformational research and explore with the audience
ways to leverage a greater return on public investment.

Sponsored by Northwestern, the University of Chicago, the University of
Illinois and the University of Virginia, Innovation, the Forum will take place
Monday, April 22^nd, 1:30 – 6:30 p.m. in Building N426 C.

The opening address will be delivered by W. Mark Crowell, Executive Director,
UVa Innovation, Associate Vice President, Research, University of Virginia,
2013 AUTM Bayh-Doyle Award Recipient.

Translational Research Forum panel discussions include:

Funding Models for Translational Research

Moderator: Norbert Riedel, PhD, Corporate Vice President, Chief Science and
Innovation Officer, Baxter International Inc

Speakers: Karen Bernstein, PhD, Chairman & Editor-in-Chief, BioCentury
Publications, Edward Lanphier, President and Chief Executive Officer, Sangamo
BioSciences, Inc., Chad A. Mirkin, Director, International Institute of
Nanotechnology, George B. Rathmann Professor of Chemistry, Professor of
Chemical and Biological Engineering, Professor of Biomedical Engineering,
Professor of Materials Science & Engineering, and Professor of Medicine,
Northwestern University, Founder of AuraSense, AuraSense Therapeutics,
Nanospher and NanoInk, and Daniel Perez, MD, Partner, Bay City Capital

Academia, Industry and Government: New Collaborative Approaches

Moderator: Vicki L. Loise, CMP, CAE, Executive Director, Association of
University Technology Managers

Speakers: Dr. Ruxandra Draghia-Akli, MD, PhD, Director, Health Directorate,
Research and Innovation DG, European Commission, Reid J. Leonard, Managing
Director, Merck Research Venture Fund , Rajesh Ranganathan, PhD, Associate
Director, Translational Research, National Institute of Neurological Disorders
and Stroke (NINDS), National Institutes of Health (NIH)

Accelerators: Leveraging Regional Resources for Growth

Moderator: Abigail Barrow, PhD, Director, Massachusetts Technology Transfer

Speakers: Richard Bendis , President & Chief Executive Officer, BioHealth
Innovation, Inc., Aaron Miscenich, President, New Orleans BioInnovation
Center, Kathleen Rousche, PhD, Program Director, NCAI, National, Heart, Lung,
and Blood Institute (NHLBI), National Institutes of Health (NIH) and Duane
Roth, Chief Executive Officer, CONNECT

To learn more about the BIO Alliance Zone, Translational Research Forum and
the various universities and academic attendees, please visit

Now open, the BIO International Convention also features theindustry's
largest partnering event, hosting a record breaking 25,000+ partnering
meetings in 2012. More than 4,000 companies participated in One-on-One
Partnering meetings in the BIO Business Forum™ and in the BIO Exhibition.
These efficient meetings foster the opportunity for companies toinitiate
business contacts in a friendly environment and schedule meetings prior to

Advance media registration is now available for qualified reporters working
full time for print, broadcast and web publications with valid press
credentials. To register, please visit here.

About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions,
state biotechnology centers and related organizations across the United States
and in more than 30 other nations. BIO members are involved in the research
and development of innovative healthcare, agricultural, industrial and
environmental biotechnology products. BIO also produces the BIO International
Convention, the world’s largest gathering of the biotechnology industry, along
with industry-leading investor and partnering meetings held around the world.
BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling
“innovations transforming our world.” Subscribe to BIOtechNOW.

Upcoming BIO Events

BIO IPCC Conference
March 25-27, 2013
San Diego, CA

BIO International Convention
April 22 – 25, 2013
Chicago, IL

World Congress on Industrial Biotechnology
June 16-19, 2013
Montreal, Canada


Biotechnology Industry Organization
Abigail Hirsch, 202-962-9230
Twitter: @IAmBiotech
Press spacebar to pause and continue. Press esc to stop.